CASTIGLIONE, FABIANA
 Distribuzione geografica
Continente #
AS - Asia 8.009
NA - Nord America 7.127
EU - Europa 5.206
SA - Sud America 899
AF - Africa 220
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.477
Nazione #
US - Stati Uniti d'America 6.770
SG - Singapore 3.615
RU - Federazione Russa 2.402
CN - Cina 1.467
VN - Vietnam 1.445
IT - Italia 912
BR - Brasile 707
HK - Hong Kong 689
DE - Germania 328
FR - Francia 276
CA - Canada 229
UA - Ucraina 223
NL - Olanda 194
FI - Finlandia 184
GB - Regno Unito 173
SE - Svezia 163
IE - Irlanda 128
BD - Bangladesh 125
JP - Giappone 122
IN - India 112
KR - Corea 76
MX - Messico 68
AR - Argentina 63
ZA - Sudafrica 61
PL - Polonia 58
CI - Costa d'Avorio 48
IQ - Iraq 46
PH - Filippine 46
TH - Thailandia 44
CO - Colombia 31
EC - Ecuador 30
PK - Pakistan 30
ES - Italia 29
TR - Turchia 29
AT - Austria 27
ID - Indonesia 26
TW - Taiwan 23
BG - Bulgaria 19
VE - Venezuela 19
MA - Marocco 18
KE - Kenya 16
EG - Egitto 15
LT - Lituania 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
PY - Paraguay 12
UZ - Uzbekistan 12
CL - Cile 11
UY - Uruguay 11
MY - Malesia 10
CZ - Repubblica Ceca 9
PE - Perù 9
JM - Giamaica 8
JO - Giordania 8
SA - Arabia Saudita 8
TN - Tunisia 8
AL - Albania 7
AU - Australia 7
AZ - Azerbaigian 7
KZ - Kazakistan 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
HN - Honduras 6
IL - Israele 6
NG - Nigeria 6
NP - Nepal 6
RS - Serbia 6
BO - Bolivia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
GT - Guatemala 5
LB - Libano 5
NI - Nicaragua 5
BE - Belgio 4
CW - ???statistics.table.value.countryCode.CW??? 4
IR - Iran 4
PA - Panama 4
RO - Romania 4
BB - Barbados 3
BW - Botswana 3
EE - Estonia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
ME - Montenegro 3
NO - Norvegia 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SI - Slovenia 3
SV - El Salvador 3
UG - Uganda 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CM - Camerun 2
CR - Costa Rica 2
Totale 21.414
Città #
Singapore 1.735
San Jose 1.053
Hong Kong 665
Ashburn 598
Chandler 588
Moscow 588
Beijing 430
Ho Chi Minh City 396
Hanoi 348
Hefei 265
Santa Clara 262
The Dalles 243
Los Angeles 201
Naples 190
Jacksonville 177
Lauterbourg 172
Millbury 150
Amsterdam 146
Boston 146
New York 131
Princeton 116
Napoli 108
Tokyo 104
Nanjing 100
Ottawa 88
Buffalo 84
Woodbridge 82
Munich 81
Boardman 78
Dallas 75
Des Moines 70
São Paulo 70
Da Nang 63
Haiphong 60
Redondo Beach 56
Wilmington 55
Seoul 53
Chicago 51
Frankfurt am Main 48
Warsaw 46
Houston 45
Seattle 45
Rome 44
Lawrence 42
Toronto 41
Montreal 40
Milan 39
Orem 39
Council Bluffs 38
Ann Arbor 33
Brooklyn 33
Atlanta 32
Nanchang 31
Denver 30
Jiaxing 30
Johannesburg 30
Mexico City 30
Nuremberg 30
Dong Ket 28
Redwood City 28
Helsinki 27
Shenyang 27
Turku 27
Hebei 26
Phoenix 26
Washington 26
Düsseldorf 25
Tianjin 25
Stockholm 24
Chennai 23
London 21
Poplar 21
Bangkok 20
Biên Hòa 20
Hải Dương 20
San Francisco 20
Falls Church 19
Manchester 18
Rio de Janeiro 18
Mumbai 17
Baghdad 16
Nairobi 15
Sofia 15
Vienna 15
Curitiba 14
Dhaka 14
Quito 14
Ankara 13
Changsha 13
Dublin 13
Philadelphia 13
Can Tho 12
Falkenstein 12
Ninh Bình 12
Norwalk 12
Thái Nguyên 12
Belo Horizonte 11
Charlotte 11
Kochi 11
Kronberg 11
Totale 11.389
Nome #
Role of 3D endoanal ultrasound in perianal fistulising Crohns's disease. Preliminary results 173
Bowel sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease 168
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with biologics 168
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents 167
Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 166
Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience 164
[Prevention of stress ulcer hemorrhage: a risk-benefit analysis]. 163
Bowel damage in Crohn's disease: direct comparison of ultrasonography- and magnetic resonance-based Lemann index. 163
Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index 161
Augmented Endoscopy for Surveillance of Colonic Inflammatory Bowel Disease: Systematic Review with Network Meta-Analysis 158
Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis 155
Multi-detector CT enterography in active inflammatory bowel disease: Image quality and diagnostic efficacy of a low-radiation high contrast protocol 155
Adherence in ulcerative colitis: an overview 154
Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography 153
Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease 152
Different profile of efficacy of thiopurines in ulcerative colitis and Crohn's disease 152
Diagnostic Accuracy of Ultrasonography in the Detection of Postsurgical Recurrence in Crohn's Disease: A Systematic Review with Meta-analysis 151
Psoriasis Features in Patients with Inflammatory Bowel Disease 151
Noninvasive diagnosis of small bowel Crohn�s Disease: combined use of Bowel sonography and Tc-99m-HMPAO Leukocyte Scintigraphy 149
Kono-type anastomosis in a patient with severe multi-recurrent Crohn's disease. 149
Gut microbiota and Crohn's disease 149
Crohn’s disease and takayasu’s arteritis: Are they associated? 148
Peritoneal inclusion cysts in Crohn's disease 145
Chemotherapy-Induced Remission of Steroid-Dependent Ulcerative Colitis Associated With Rectal Hodgkin Lymphoma 144
Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases 143
Evaluation of nutritional adequacy in adult patients with Crohn's disease: a cross-sectional study. 141
The burden of anaemia in patients with inflammatory bowel diseases 140
The impact of a dedicated contact centre on the clinical outcome of patients with inflammatory bowel disease during the COVID-19 outbreak 136
Diagnostic Accuracy of 3-Dimensional Endoanal Ultrasound in Identifying Perianal Crohn's Fistulas 135
Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. 134
Ultrasonography Tight Control and Monitoring in Crohn's Disease During Different Biological Therapies: A Multicenter Study 133
Association between health-related quality of life and nutritional status in adult patients with Crohn’s disease 133
Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers 133
Diagnostic Efficacy of Single-Pass Abdominal Multidetector-Row CT: Prospective Evaluation of a Low Dose Protocol. 131
One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing. 131
Effectiveness of Partial Enteral Nutrition as Add-On to Biologics in Patients With Refractory and Difficult-to-Treat Crohn’s Disease: A Pilot Study 130
Small bowel Crohn's disease: comparison of enteroclysis, bowel sonography and Tc-99m-HMPAO leukocyte scintigraphy 130
Combined endoscopic/sonographic-based risk matrix model for predicting one-year risk of surgery: A prospective observational study of a tertiary centre severe/refractory crohn's disease cohort 130
Diagnostic accuracy of confocal laser endomicroscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis. 129
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers 128
Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease: The SuPREMe-CD Study - A Randomized Clinical Trial. 128
Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition 128
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study 124
Orocoecal transit time and bacterial overgrowth in patients with Crohn’s disease 123
Ultrasonography-Based Management of Sclerosing Mesenteritis: From Diagnosis to Follow-Up 122
Dactylitis in enteropathic spondyloarthritis 122
Nutritional Rehabilitation in Patients with Malnutrition Due to Crohn's Disease 122
Cyclic Neutropenia Mimicking Crohn's Disease: Two Case Reports and a Narrative Review 121
Reactivation of hepatitis B or C in patients with IBD receiving immunosuppressive drugs. A multicentre study 121
Timing strategies of direct-acting antivirals and biologics administration in HCV-infected subjects with inflammatory bowel diseases 121
Preventing recurrence in Crohn's disease: the Kono-S anastomosis with two-layer technique. 121
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection 120
Hepatitis B and C virus infection in Crohn's Disease 120
New Predictive Equations for Estimating Resting Energy Expenditure in Adults With Crohn's Disease. 120
Infliximab in the treatment of Crohn�s disease: Predictors of response in an Italian multicentric open study 119
Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome: a novel association. 119
Monster parastomal pyoderma gangrenosum effectively treted by topical tacrolimus. 119
Post-operative morbidity in Crohn's disease: what is the impact of patient-, disease- and surgery-related factors? 119
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study 118
Successful treatment of therapy-resistant metastatic Crohn's desiase with infliximab 118
Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course. 118
The Impact of Inflammatory Bowel Diseases on Patients' Quality of Life and Work Functionality An Observational Study 117
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 117
Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease 117
Parietal Healing in Patients With Crohn's Disease on Maintenance Treatment With Biologics 117
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection. 116
Escalating dose of adalimumab as monotherapy to treat unusual giant and refractory oral-pharyngeal ulcerations in Crohn's disease 116
The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders 116
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). 114
Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment 113
Bowel sonography in predicting post-operative course of Crohn’s disease. 113
Assessment of bioelectrical phase angle as a predictor of nutritional status in patients with Crohn's disease: A cross sectional study 113
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 113
Infliximab in the treatment of seronegative spondyloarthropathies 112
Cross-sectional evaluation of transmural healing in Crohn's disease: Mural and mesenteric parameters -€” Authors'€™ reply 112
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 111
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 111
Asymptomatic microscopic colitis induced by secukinumab 111
Lower prevalence of diverticulosis in patients with ulcerative colitis. 111
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study. 111
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial 111
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. 111
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. 110
Therapy in elderly IBD patients 109
A Mesalazine tablet in the distal ileum of a patient with Crohn’s Disease 109
Serum Interleukin 6, Controlling Nutritional Status (CONUT) Score and Phase Angle in Patients with Crohn's Disease 108
Il ruolo dell'ecografia intestinale nel predire il decorso clinico post-operatorio della malattia di Crohn 108
Amino acid profiles, disease activity, and protein intake in adult patients with Crohn's disease 107
Psoriasis is not a risk factor for arthritis in patients with Crohn’s disease Rheumatology, 41:115, 2002. 106
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study 106
Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era 105
Enteropathic spondyloarthritis: from diagnosis to treatment. 104
Noninvasive diagnosis of small bowel Crohn's disease: direct comparison of bowel sonography and magnetic resonance enterography. 104
Accuracy of enteroclysis in Crohn's disease of the small bowel: a retrospective study. 103
Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models? 103
Appropriateess of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement 102
Lower prevalence of diverticulosis in patients with ulcerative colitis. 102
Reply to Dr Gearry’s letter. 102
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 102
Discovertebral Erosions in Patients with Enteropathic Spondyloarthritis. 101
Totale 12.712
Categoria #
all - tutte 71.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022923 14 7 8 14 9 25 16 32 123 48 190 437
2022/20231.268 185 138 20 125 145 147 7 128 177 124 52 20
2023/20241.041 25 115 89 62 53 105 91 127 19 15 199 141
2024/20255.587 275 324 30 58 134 221 656 342 415 611 1.962 559
2025/202610.707 1.174 828 1.093 872 1.923 477 1.179 511 1.439 624 287 300
2026/2027313 313 0 0 0 0 0 0 0 0 0 0 0
Totale 21.789